Six-Year Journey to Diagnosis of Rare Autoimmune Muscle Disorder

A 38-year-old woman faced a frustrating six-year decline in muscle strength before receiving a vital diagnosis. Her journey began with subtle weakness in her arms, making it difficult to grip objects. Unfortunately, her issues were misattributed to anemia by multiple practitioners, leaving the underlying autoimmune condition undiagnosed.

A Sudden Medical Crisis

Her condition escalated suddenly when she lost the ability to swallow, a sign that finally prompted further investigation. By the time she reached the hospital, she struggled to lift her legs and faced a real risk of aspiration pneumonia due to her swallowing difficulties.

Key Diagnostic Findings

The turning point in her diagnosis was a lab test that revealed a strong presence of antibodies against U1 ribonucleoprotein. This finding is associated with mixed connective tissue disease, a rare autoimmune disorder marked by overlapping symptoms of lupus, myositis, and sclerosis. Although the condition affects a limited population—estimated at 3 to 37 per 100,000 people—it predominantly impacts women.

Upon her hospital admission, clinical evaluations indicated alarming weakness, particularly in her hip flexors and quadriceps, where she scored only 2 out of 5. Fortunately, her cranial nerves were functioning correctly. The absence of typical symptoms often linked with autoimmune disorders contributed to the delay in her diagnosis.

Laboratory and Electrophysiological Insights

Lab tests indicated a dramatic rise in muscle enzyme levels, with creatine kinase at 9,883 IU/L—about 68 times higher than normal. Additionally, inflammatory biomarkers were elevated, supporting the suspicion of a severe inflammatory myopathy. Other antibodies typically associated with florid lupus were absent, narrowing down the diagnosis.

Electrodiagnostic testing confirmed nerve conductivity was normal. However, the electromyography revealed patterns typical of a chronic situation, suggesting that her muscles had been under duress for years. Imaging corroborated this, showing inflammation in her thigh muscles.

Rapid Response and Recovery

The urgency of her swallowing difficulties led to immediate treatment. She received a three-day regimen of high-dose intravenous methylprednisolone, and within days, significant improvements were noted. Her capacity to swallow returned enough for safe oral intake, and her muscle strength began to recover. Transitioning to oral medication, her condition quickly improved, and follow-up tests showed a dramatic decrease in creatine kinase levels.

Lessons and Recommendations

The report highlights the sudden onset of dysphagia as a critical warning sign. Inflammation targeting the pharyngeal muscles can lead to serious complications if not promptly addressed. Clinicians are advised to consider new swallowing difficulties in patients with muscle weakness as urgent cases demanding immediate intervention.

Classification of her condition, however, became a point of debate. Although her antibody presence aligns with mixed connective tissue disease, she lacked the classic symptoms necessary for full classification. This distinction is crucial as it informs treatment approaches and expectations for future disease progression.

Moreover, the patient's untreated anemia raises questions about the need for comprehensive evaluation in similar cases where muscle weakness coexists with unexplained anemia. A systematic approach to testing could facilitate earlier identification and treatment.

In summary, this case serves as a reminder that autoimmune myopathy should be considered in any patient presenting with longstanding unexplained weakness. A simple blood test for antibodies could pave the way for timely diagnosis and intervention, ultimately improving patient outcomes.